Search:
   

Tuesday, January 27, 2015

Equity Trader Alert #2015 - 13
Reverse Split and CUSIP Change Information for Cleveland BioLabs, Inc. (CBLI)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Cleveland BioLabs, Inc. (CBLI) will effect a one for twenty (1-20) reverse split of its outstanding common stock. The reverse split will be effective at the opening of business on Wednesday, January 28, 2015. In conjunction with the reverse split, the CUSIP number will change to 185860202.

If you would like to register as a market maker in CBLI, contact Nasdaq Trading Services at +1 212 231 5100.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile